![](/img/cover-not-exists.png)
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Adingupu, Damilola D., Göpel, Sven O., Grönros, Julia, Behrendt, Margareta, Sotak, Matus, Miliotis, Tasso, Dahlqvist, Ulrika, Gan, Li-Ming, Jönsson-Rylander, Ann-CathrineVolume:
18
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-019-0820-6
Date:
December, 2019
File:
PDF, 1.54 MB
english, 2019